Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8134719 | 0.80 | SLC6A1 (0.35) | CYP2C19CYP1A2 | |
| SCHEMBL6534666 | 0.74 | SLC6A1 (0.41) | CYP1A2 | |
| SCHEMBL31087758 | 0.73 | CYP2C19 (0.36) | CYP2C19CYP1A2USP2ALDH1A1LMNA | |
| SCHEMBL2094040 | 0.73 | USP2 (0.40) | CYP2C19CYP1A2USP2ALDH1A1LMNA | |
| SCHEMBL16447201 | 0.73 | USP2 (0.40) | CYP2C19CYP1A2USP2ALDH1A1LMNA | |
| SCHEMBL2284853 | 0.73 | USP2 (0.40) | CYP2C19CYP1A2USP2ALDH1A1LMNA | |
| SCHEMBL1287846 | 0.71 | USP2 (0.39) | CYP2C19CYP1A2USP2ALDH1A1LMNA | |
| SCHEMBL28859056 | 0.70 | — | — | |
| SCHEMBL28384638 | 0.70 | — | — | |
| SCHEMBL3730156 | 0.70 | USP2 (0.37) | CYP2C19CYP1A2USP2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4466023-A1 | PROCESS FOR THE PREPARATION OF ANTIBODY-DRUG CONJUGATES | Mc SAF (FR) | 2024-11-27 | — | — | EP | disclosed |
| WO-2023135397-A1 | PROCESS FOR THE PREPARATION OF ANTIBODY-DRUG CONJUGATES | MC SAF (FR) | 2023-07-20 | — | — | WO | disclosed |
| JP-2023067778-A | Manufacturing method of nanodiamond coordinated with radioactive metal gallium | 行政院原子能委員會核能研究所 | 2023-05-16 | — | — | JP | disclosed |
| CN-113368264-B | Radiolabeled cinnamycin, preparation method and application thereof | 南方医科大学南方医院 | 2022-09-30 | — | — | CN | disclosed |